Multisystem burden of neurofibromatosis 1 in Denmark: registry- and population-based rates of hospitalizations over the life span

被引:19
作者
Kenborg, Line [1 ]
Duun-Henriksen, Anne Katrine [2 ]
Dalton, Susanne O. [3 ]
Bidstrup, Pernille E. [3 ]
Doser, Karoline [3 ]
Rugbjerg, Kathrine [1 ]
Pedersen, Camilla [1 ]
Kroyer, Anja [1 ]
Johansen, Christoffer [3 ,4 ]
Andersen, Klaus Kaae [2 ]
Ostergaard, John R. [5 ]
Hove, Hanne [6 ,7 ]
Sorensen, Sven Asger [8 ]
Riccardi, Vincent M. [9 ]
Mulvihill, John J. [10 ]
Winther, Jeanette F. [1 ,11 ]
机构
[1] Danish Canc Soc Res Ctr, Childhood Canc Res Grp, Copenhagen, Denmark
[2] Danish Canc Soc Res Ctr, Stat & Pharmacoepidemiol, Copenhagen, Denmark
[3] Danish Canc Soc Res Ctr, Survivorship Unit, Copenhagen, Denmark
[4] Copenhagen Univ Hosp, Rigshosp, Dept Oncol, Copenhagen, Denmark
[5] Aarhus Univ Hosp, Ctr Rare Dis, Dept Pediat, Aarhus, Denmark
[6] Copenhagen Univ Hosp, Dept Clin Genet, Copenhagen, Denmark
[7] Copenhagen Univ Hosp, Dept Clin Genet, RAREDIS Database, Sect Rare Dis, Copenhagen, Denmark
[8] Univ Copenhagen, Panum Inst, Inst Cellular & Mol Med, Dept Neurogenet, Copenhagen, Denmark
[9] Neurofibromatosis Inst, La Crescenta, CA USA
[10] Univ Oklahoma, Dept Pediat, Oklahoma City, OK USA
[11] Aarhus Univ, Fac Hlth, Dept Clin Med, Aarhus, Denmark
关键词
neurofibromatosis; 1; hospitalizations; population-based; cohort study; VONRECKLINGHAUSEN NEUROFIBROMATOSIS; NERVOUS-SYSTEM; FOLLOW-UP; TYPE-1; CANCER; INDIVIDUALS; PREVALENCE; MORTALITY; DISORDER; EPILEPSY;
D O I
10.1038/s41436-020-0769-6
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose The aim was to assess lifetime risk for hospitalization in individuals with neurofibromatosis 1 (NF1). Methods The 2467 individuals discharged with a diagnosis indicating NF1 or followed in a clinical center for NF1 were matched to 20,132 general population comparisons. Based on diagnoses in 12 main diagnostic groups and 146 subcategories, we calculated rate ratios (RRs), absolute excess risks (AERs), and hazard ratios for hospitalizations. Results The RR for any first hospitalization among individuals with NF1 was 2.3 (95% confidence interval 2.2-2.5). A high AER was seen for all 12 main diagnostic groups, dominated by disorders of the nervous system (14.5% of all AERs), benign (13.6%) and malignant neoplasms (13.4%), and disorders of the digestive (10.5%) and respiratory systems (10.3%). Neoplasms, nerve and peripheral ganglia disease, pneumonia, epilepsy, bone and joint disorders, and intestinal infections were major contributors to the excess disease burden caused by NF1. Individuals with NF1 had more hospitalizations and spent more days in hospital than the comparisons. The increased risk for any hospitalization was observed for both children and adults, with or without an associated cancer. Conclusion NF1 causes an overall greater likelihood of hospitalization, with frequent and longer hospitalizations involving all organ systems throughout life.
引用
收藏
页码:1069 / 1078
页数:10
相关论文
共 38 条
  • [1] Growth rate characteristics of acoustic neuromas associated with neurofibromatosis type 2
    Abaza, MM
    Makariou, E
    Armstrong, M
    Lalwani, AK
    [J]. LARYNGOSCOPE, 1996, 106 (06) : 694 - 699
  • [2] Gastrointestinal and Retroperitoneal Manifestations of Type 1 Neurofibromatosis
    Basile, Ursula
    Cavallaro, Giuseppe
    Polistena, Andrea
    Giustini, Sandra
    Orlando, Gennaro
    Cotesta, Dario
    Petramala, Luigi
    Letizia, Claudio
    Calvieri, Stefano
    De Toma, Giorgio
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2010, 14 (01) : 186 - 194
  • [3] Neurological complications of neurofibromatosis type 1 in adulthood
    Créange, A
    Zeller, J
    Rostaing-Rigattieri, S
    Brugières, P
    Degos, JD
    Revuz, J
    Wolkenstein, P
    [J]. BRAIN, 1999, 122 : 473 - 481
  • [4] DEFINELICHT S, 2017, PLOS MED, V14
  • [5] Constipation in adults with neurofibromatosis type 1
    Ejerskov, Cecilie
    Krogh, Klaus
    Ostergaard, John R.
    Fassov, Janne L.
    Haagerup, Annette
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2017, 12
  • [6] FERNER RE, 2010, PRACT NEUROL, V10, P82
  • [7] Neuro-fibromatosis 1 and neuro-fibromatosis 2: a twenty first century perspective
    Ferner, Rosalie E.
    [J]. LANCET NEUROLOGY, 2007, 6 (04) : 340 - 351
  • [8] Cardiovascular disease in neurofibromatosis 1: Report of the NF1 cardiovascular task force
    Friedman, JM
    Arbiser, J
    Epstein, JA
    Gutmann, DH
    Huot, SJ
    Lin, AE
    McManus, B
    Korf, BR
    [J]. GENETICS IN MEDICINE, 2002, 4 (03) : 105 - 111
  • [9] Friedman JM, 1997, AM J MED GENET, V70, P138, DOI 10.1002/(SICI)1096-8628(19970516)70:2<138::AID-AJMG7>3.0.CO
  • [10] 2-U